First-time handling of different inhalers by chronic obstructive lung disease patients.

First-time handling of different inhalers by chronic obstructive lung disease patients. Exp Lung Res. 2020 Jul 02;:1-12 Authors: Harb HS, Laz NI, Rabea H, Abdelrahim MEA Abstract Background: There is a lack of guidance on inhaler device selection and how to individualize inhaler choice when prescribed for the first-time.Aim of the work: To compare different inhalers regarding ease of use and number of counseling attempts needed for correct handling in subjects with a first experience to such inhalers; also, to investigate if there is a correlation between total correct steps achievements and patient demographics/clinical variables.Method: An open-label, non-drug interventional, cross-over study was conducted including 180 Egyptian patients with chronic obstructive pulmonary disease (COPD). The study evaluated handling of the most common inhalers in subjects with a first experience with them before hospital discharge. Subjects were randomized to handle 10 placebo inhalers including: [metered dose inhaler (pMDI), Aerolizer, Handihaler, Turbohaler, Diskus, Breezhaler, Ellipta, Easyhaler, Diskhaler, and Respimat] without receiving verbal or demonstrative instruction with allowable access to the patient information leaflets in native language supported by figures with enough time to read (baseline assessment). Subjects were then crossed-over to other inhalers with a first experience randomly. Inhalers with a reported past-experience were excluded. Inhaler-tech...
Source: Experimental Lung Research - Category: Respiratory Medicine Tags: Exp Lung Res Source Type: research

Related Links:

BACKGROUND: Elderly residents in nursing homes have multiple comorbidities (including cognitive and psycho-behavioral pathologies, malnutrition, heart failure, diabetes, chronic obstructive pulmonary disease, and renal failure) and use multiple medications...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
PMID: 32735164 [PubMed - as supplied by publisher]
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Am J Respir Cell Mol Biol Source Type: research
Authors: Barnes PJ Abstract INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a heterogeneous syndrome and may comprise several different phenotypes that are driven by different molecular mechanisms (endotypes). Several different clinical, genetic and inflammatory phenotypes of COPD have been recognised and this may lead to more precise effective therapies. AREAS COVERED: The different clinical phenotypes, including smoking versus non-smoking COPD, small airway disease versus emphysema, non-exacerbators versus frequent exacerbators are discussed. Rare genetic endotypes (alpha1-antitrypsin deficiency...
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Tags: Expert Rev Respir Med Source Type: research
Cigarette smoke extract triggers neoplastic change in lungs and impairs locomotor activity through wnt3a-β-catenin signaling in aged COPD rodent model. Exp Lung Res. 2020 Jul 30;:1-14 Authors: Devi K, Moharana B Abstract BACKGROUND: Chronic cigarette smoking primes immense decline in lung functions and retardation of motor functions with increase in age. This raise the question of whether age status overwhelm the susceptibility to smoking induced lung inflammatory diseases and neuro-motor dysfunctions. METHODS: To study the hypothesis 11-12 month old aged wistar rats (n = ...
Source: Experimental Lung Research - Category: Respiratory Medicine Tags: Exp Lung Res Source Type: research
This study aimed to investigate whether the pharmacological SIRT1 activator SRT2104 protects against AECII senescence in rats with emphysema. Our findings confirmed that SRT2104 administration reduced the pathological characteristics of emphysema and improved lung function parameters, including pulmonary resistance, pulmonary dynamic compliance, and peak expiratory flow. Moreover, SRT2104 treatment upregulated the expression of surfactant proteins A and C, SIRT1, and forkhead box O 3a (FoxO3a), decreased senescence-associated-β-galactosidase (SA-β-gal) activity, increased SIRT1 deacetylase activity, and downregul...
Source: COPD: Journal of Chronic Obstructive Pulmonary Disease - Category: Respiratory Medicine Tags: COPD Source Type: research
Conclusions-Smoking cessation has been shown to be beneficial at any age. However, even after quitting smoking, the length of time a person smoked is reflected in current health measures among people aged 65 and over. PMID: 32730739 [PubMed - as supplied by publisher]
Source: National health statistics reports - Category: American Health Tags: Natl Health Stat Report Source Type: research
Condition:   Pulmonary Disease, Chronic Obstructive Intervention:   Sponsors:   Royal Free Hospital NHS Foundation Trust;   Imperial College London;   Acurable Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Asthma;   COPD Interventions:   Drug: Budesonide;   Drug: Formoterol Sponsor:   Intech Biopharm Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   COPD;   COPD Exacerbation Intervention:   Other: biomarker identification Sponsor:   IRCCS San Raffaele Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Asthma;   COPD Interventions:   Drug: Budesonide;   Drug: Formoterol Sponsor:   Intech Biopharm Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chronic Obstructive Pulmonary | Egypt Health | Respiratory Medicine | Study